Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Crescent Biopharma, Inc. - Common Stock (NQ:CBIO)

18.02 -0.05 (-0.28%)
Streaming Delayed Price Updated: 1:36 PM EDT, May 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Crescent Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Which stocks are moving on Friday? ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma Announces Grants of Inducement Awards
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma Announces Grants of Inducement Awards
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma Announces Grants of Inducement Awards
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma to Present at March Investor Conferences
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma Announces Grants of Inducement Awards
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma Announces Grants of Inducement Awards
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Crescent Biopharma Announces Grants of Inducement Awards
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
The Deal That Sent Crescent Biopharma Shares Surging Over 40% Pre-Market Today ↗
Crescent Biopharma announced a strategic partnership with the Chinese firm Sichuan Kelun-Biotech Biopharmaceutical Co. to fast-track its global oncology pipeline. 
Via Stocktwits
News headline image
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
From Crescent Biopharma, Inc.
Via GlobeNewswire
News headline image
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
From Crescent Biopharma, Inc.; Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Via GlobeNewswire
News headline image
Crescent Biopharma Announces Grants of Inducement Awards
From Crescent Biopharma
Via GlobeNewswire
News headline image
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
From Crescent Biopharma
Via GlobeNewswire
News headline image
Crescent Biopharma to Present at November Investor Conferences
From Crescent Biopharma
Via GlobeNewswire
News headline image
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
From Crescent Biopharma
Via GlobeNewswire
News headline image
Crescent Biopharma to Present at September Investor Conferences
From Crescent Biopharma
Via GlobeNewswire
News headline image
This Devon Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
This Arm Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday ↗
 
Via Benzinga
News headline image
Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
From Crescent Biopharma
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer
From Crescent Biopharma
Via GlobeNewswire
News headline image
Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.